Proposed Transdermal Treatment for Veterans with PTSD a Top Priority of Skinvisible, Inc. (SKVI) and Quoin Pharmaceuticals
Proposed transdermal product will help veterans struggling with PTSD and suicidal thoughts Majority of suicides among military veterans are among those 50 and older Suicide rate for U.S. women veterans was 2.5 times higher than civilian adult women Presidential executive order signed January 9, 2018, focuses on providing mental health care to former service members Topical and transdermal product development company Skinvisible, Inc. (OTCQB: SKVI) and its patented Invisicare® technology could provide significant relief to veterans with post-traumatic stress disorder through a proposed transdermal treatment the company expects to develop as it merges with Quoin Pharmaceuticals Ltd. The proposed merger,…